Edward A. Blechschmidt is Director at HEALTHSOUTH CORP (HLS). They have made 13 open-market trades across 5 companies since 2006, most recently 2017-11-21.
CIK 0001186623
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
10 open-market purchases totalling $258K since 2006, against 3 sales. Across 10 scored buys the stock is down 2.2% at ninety days, and 2.4 points behind the S&P over the same stretch.
10 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 50% | 50% |
| Avg Move | -6.3% | -2.2% | -2.2% |
| Alpha | -10.6% | -2.4% | -2.4% |
| Scored | 10 | 10 | 10 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LIOX | SELL | 2014-03-06 | 2014-03-10 | $7.23 | $253K | -13.6% | -5.2% | -5.2% |
| LIOX | BUY | 2013-05-16 | 2013-05-17 | $2.63 | $26K | -13.6% | -5.2% | -5.2% |
| HLS | BUY | 2012-03-06 | 2012-03-06 | $20.01 | $40K | -4.5% | +0.8% | +0.8% |
| HLS | BUY | 2012-03-02 | 2012-03-05 | $20.01 | $4K | -4.5% | +0.8% | +0.8% |
| HLS | BUY | 2012-03-01 | 2012-03-01 | $20.45 | $20K | -4.5% | +0.8% | +0.8% |
| DMND | SELL | 2010-10-13 | 2010-10-13 | $41.25 | $83K | +2.0% | +0.2% | +0.2% |
| LIOX | BUY | 2008-12-08 | 2008-12-08 | $0.93 | $8K | -13.6% | -5.2% | -5.2% |
| HLS | BUY | 2008-11-20 | 2008-11-21 | $9.36 | $37K | -4.5% | +0.8% | +0.8% |
| HLS | BUY | 2008-11-12 | 2008-11-14 | $10.41 | $21K | -4.5% | +0.8% | +0.8% |
| CBRX | SELL | 2006-06-05 | 2006-06-06 | $4.18 | $75K | N/A | N/A | N/A |
| OPTN | BUY | 2006-05-25 | 2006-05-26 | $11.25 | $44K | -4.5% | -5.0% | -5.0% |
| OPTN | BUY | 2006-05-11 | 2006-05-15 | $11.22 | $12K | -4.5% | -5.0% | -5.0% |
| OPTN | BUY | 2006-05-11 | 2006-05-25 | $11.25 | $44K | -4.5% | -5.0% | -5.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| Total |
| $3.8M |
Shares reported on the most recent Form 4, priced at the 2017-03-02 close. 2 holdings could not be priced and are excluded from the total.